These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3229458)

  • 1. In vitro glycation of red blood cell proteins: high levels of glucose lower lipid fluidity of erythrocyte membranes.
    Watała C
    Exp Pathol; 1988; 33(4):233-8. PubMed ID: 3229458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonenzymatic protein glycosylation. I. Lowered erythrocyte membrane fluidity in juvenile diabetes.
    Watała C; Zawodniak M; Bryszewska M; Nowak S
    Ann Clin Res; 1985; 17(6):327-30. PubMed ID: 4096489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.
    Watala C; Winocour PD
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):513-9. PubMed ID: 1457612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the glycation of erythrocyte membrane proteins and membrane fluidity.
    Bryszewska M; Szosland K
    Clin Biochem; 1988 Jan; 21(1):49-51. PubMed ID: 3345599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte membrane fluidity as a marker of diabetic retinopathy in type 1 diabetes mellitus.
    Bianchetti G; Viti L; Scupola A; Di Leo M; Tartaglione L; Flex A; De Spirito M; Pitocco D; Maulucci G
    Eur J Clin Invest; 2021 May; 51(5):e13455. PubMed ID: 33210748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in fluidity of erythrocyte membranes after storage of erythrocytes and regeneration of cellular ATP level.
    Jarolím P; Mircevová L
    Biochim Biophys Acta; 1982 Jun; 688(2):460-4. PubMed ID: 7104335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes.
    Miller JA; Gravallese E; Bunn HF
    J Clin Invest; 1980 Apr; 65(4):896-901. PubMed ID: 7358849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose.
    Nandhini TA; Anuradha CV
    Clin Chim Acta; 2003 Oct; 336(1-2):129-35. PubMed ID: 14500045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a relationship between protein glycation and red blood cell membrane fluidity.
    Birlouez-Aragon I; Scalbert-Menanteau P; Morawiec M; Shafiezadeh M
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1107-13. PubMed ID: 2390079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluidity of intact erythrocyte membranes. Correction for fluorescence energy transfer from diphenylhexatriene to hemoglobin.
    Plásek J; Cermáková D; Jarolím P
    Biochim Biophys Acta; 1988 Jun; 941(2):119-22. PubMed ID: 3382643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.
    Waczulíkova I; Sikurová L; Cársky J; Strbová L; Krahulec B
    Gen Physiol Biophys; 2000 Dec; 19(4):381-92. PubMed ID: 11409841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects.
    Winocour PD; Watala C; Kinglough-Rathbone RL
    Thromb Haemost; 1992 May; 67(5):567-71. PubMed ID: 1519216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloxan-induced alterations in composition and dynamics of red blood cell membranes. I. Effect of alloxan on intact red blood cells and isolated erythrocyte membranes.
    Watała C; Budziejewska A; Jóźwiak Z
    Biochem Pharmacol; 1989 Jun; 38(11):1793-8. PubMed ID: 2735937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycaemia alters the physico-chemical properties of proteins in erythrocyte membranes of diabetic patients.
    Watala C
    Int J Biochem; 1992 Nov; 24(11):1755-61. PubMed ID: 1333422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins.
    Winocour PD; Watala C; Perry DW; Kinlough-Rathbone RL
    Thromb Haemost; 1992 Nov; 68(5):577-82. PubMed ID: 1455404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte membrane microviscosity in diabetes.
    Otsuji S; Baba Y; Kamada T
    Horm Metab Res Suppl; 1981; 11():97-102. PubMed ID: 6274779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-enzymatic glycosylation of proteins].
    Turyna B; Guzdek A
    Postepy Biochem; 1985; 31(3-4):555-67. PubMed ID: 3916025
    [No Abstract]   [Full Text] [Related]  

  • 18. Human red blood cell membrane potential and fluidity in glucose solutions.
    Zavodnik IB; Piasecka A; Szosland K; Bryszewska M
    Scand J Clin Lab Invest; 1997 Feb; 57(1):59-63. PubMed ID: 9127458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of spectrin and deformability defects in diabetic erythrocytes.
    Schwartz RS; Madsen JW; Rybicki AC; Nagel RL
    Diabetes; 1991 Jun; 40(6):701-8. PubMed ID: 2040386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable glycation of serum proteins in patients with diabetes mellitus.
    Couturier M; Amman H; Des Rosiers C; Comtois R
    Clin Invest Med; 1997 Apr; 20(2):103-9. PubMed ID: 9088666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.